Document is current
Any future updates will be listed below
-
Authors
Yeap, Swan Sim https://orcid.org/0000-0002-0474-3667
Abu Amin, Syamsul Rizal
Baharuddin, Hazlyna
Koh, Kar Chai
Lee, Joon Kiong
Lee, Verna Kar Mun
Mohamad Yahaya, Nor Hamdan
Tai, Cheh Chin
Tan, Maw Pin
-
Funding
Funding for this research was provided by:
Mylan Healthcare Sdn Bhd
- License Information
-
More Information
Article History
Received: 15 September 2020
Accepted: 18 May 2021
First Online: 4 June 2021
Declarations
:
: Not applicable as per Guideline 1: Waiver for Medical Review & Ethics Committee review and approval for research not involving human subject, released by the Ministry of Health Malaysia (31 Oct 2006)<b>.</b>
: Not applicable.
: Outside the submitted work: SSY reports personal fees from Amgen, Mylan & Novartis, and non-financial support from Mylan & Abbvie. SRAA reports personal fees from Mylan & Pfizer. HB reports personal fees from Mylan, Roche, Sanofi, Boehringer-Ingelheim & Pfizer. KCK reports personal fees from Abbott, Astra Zeneca, CIPLA, GSK, Mylan, Sanofi, Takeda and Xepa. JKL reports personal fees from Amgen & Mylan. VKML reports personal fees from Mylan & Sanofi Pasteur, and non-financial support from Mylan, Sanofi Pasteur & Torrent. NHMY reports personal fees from Mylan, Hyphens, Zimmer & Smith and Nephew. CCT reports personal fees from Mylan, Stryker & Anthroworld. MPT reports personal fees from Mylan, Abbott, DCH Auriga, Pfizer & Sanofi.
